MET

The MET gene, also known as mechanistic target of rapamycin, is a receptor tyrosine kinase involved in embryonic development, wound healing, organ regeneration, and tissue remodeling.

Associated diseases 

Papillary renal cell carcinoma, hepatocellular carcinoma, Head and neck cancers

Did you know 

MET alterations occur in approximately 1% to 6% of non-small-cell lung cancer (NSCLC) patients

Additional info 

The MET gene, also known as mechanistic target of rapamycin, is a receptor tyrosine kinase involved in embryonic development, wound healing, organ regeneration, and tissue remodeling. It regulates proliferation, scattering, morphogenesis, and cellular survival.